Effect of Bergamot Juice on LDL Cholesterol Level in Healthy Subjects

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05589636

562/2021/SPER /UNIPR

Ages 18-75
All Genders
Accepts Healthy Volunteers

Study Summary

A single-centre, randomized (1:1), open label, controlled study to assess the lipid-lowering effect at 12 weeks of 400 cc/die bergamot juice consumption compared to free diet in healthy subjects

Eligibility Criteria

Inclusion

Inclusion Criteria:

Caucasian persons of both sexes aged ≥18 and ≤75 years
ability to understand the methods, purposes and implications of the study, and to givefree and informed consent

Exclusion

Exclusion Criteria:

Diabetes mellitus defined according to ADA criteria
Present or past history of alcohol or drug abuse or organ failure (kidney and liver)
Tumor pathologies in the last 5 years;
Past or present cerebro-vascular diseases;
Subjects taking drugs or supplements active on the lipid profile;
Pregnancy or breastfeeding
Presence of severe or monogenic dyslipidemia
Use of antibiotics in the last three months before enrollment
Subjects who are on a diet for any reason
Individuals who have intentionally or unintentionally lost 3 kg or more of body weightin the past 3 months.
Known allergies to some components of the product
Subjects who do not like bergamot

Study Design

February 10, 2022

July 31, 2023

Study Description

Cardiovascular diseases (CV) are the first cause of morbidity and mortality in industrialized countries. Hypercholesterolemia is the main CV risk factor: high cholesterol values are directly and linearly correlated with CV events and mortality in the absence of a threshold value. Intervention studies show unequivocally how the decrease in cholesterol levels significantly reduces CV risk. Bergamot juice is considered a possible food with nutraceutical activity, especially as regards the control of blood cholesterol levels. It is now known that bergamot juice has chemical components that can positively affect blood cholesterol levels. These compounds are called 3-hydroxy-3-methyl flavonoids (HMG-flavonoids) and are peculiar to some citrus plants and in particular to the Citrus bergamia species. The aim of this study is to provide clinical evidence of the effect of these metabolites on cholesterol levels. Specifically, a single-centre, randomized (1:1), open label, controlled study is conducted in healthy subjects to evaluate the possible lipid-lowering effects at 12 weeks of 400 cc/die of bergamot juice consumption compared to a free diet. Changes in the following parameters: body mass index (BMI kg/m²), waist circumference, glycemia, insulin, glycated hemoglobin (HbA1C), total cholesterol, HDL cholesterol and triglycerides, plasma levels of inflammatory cytokines, C-reactive protein (hsCRP) and Proprotein convertase subtilisin / kexin type 9 (PCSK9) are also investigated at 12 weeks.

Connect with a study center

University of Parma, Department of Medicine and Surgery
Parma, 43126
Italy
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.